www.prnewswire.com Open in urlscan Pro
2606:4700::6812:1855 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://c212.net/c/link/?t=0&l=en&o=3758271-1&h=1125481483&u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fc...
Effective URL:
https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-no...
Submission: On January 18 via api (January 18th 2023, 12:22:02 am UTC) from CH — Scanned from DE

Summary HTTP 78 Redirects Links 44 Behaviour Indicators

Summary

This website contacted 12 IPs in 4 countries across 11 domains to perform 78 HTTP transactions. The main IP is 2606:4700::6812:1855, located in United States and belongs to CLOUDFLARENET, US. The main domain is www.prnewswire.com. The Cisco Umbrella rank of the primary domain is 30353.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on May 28th 2022. Valid for: a year.

This is the only time www.prnewswire.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	13.225.78.23 13.225.78.23	16509 (AMAZON-02) (AMAZON-02)
53	2606:4700::68... 2606:4700::6812:1855	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	99.86.240.36 99.86.240.36	16509 (AMAZON-02) (AMAZON-02)
3	2606:4700::68... 2606:4700::6812:12d1	13335 (CLOUDFLAR...) (CLOUDFLARENET)
8	2a02:26f0:f70... 2a02:26f0:f700:495::1e80	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
2	52.48.61.43 52.48.61.43	16509 (AMAZON-02) (AMAZON-02)
1	2600:9000:214... 2600:9000:214f:3000:18:1fcd:351:7bc1	16509 (AMAZON-02) (AMAZON-02)
6	2606:4700::68... 2606:4700::6810:9440	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	3.231.82.137 3.231.82.137	14618 (AMAZON-AES) (AMAZON-AES)
1	34.254.165.240 34.254.165.240	16509 (AMAZON-02) (AMAZON-02)
1 1	54.171.1.252 54.171.1.252	16509 (AMAZON-02) (AMAZON-02)
1	15.236.117.205 15.236.117.205	16509 (AMAZON-02) (AMAZON-02)
1	2606:4700::68... 2606:4700::6812:1a55	13335 (CLOUDFLAR...) (CLOUDFLARENET)
78	12

1 13.225.78.23 (United States) 1 redirects

ASN16509 (AMAZON-02, US)
PTR: server-13-225-78-23.fra2.r.cloudfront.net

c212.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

53 2606:4700::6812:1855 (United States)

ASN13335 (CLOUDFLARENET, US)

www.prnewswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 99.86.240.36 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-99-86-240-36.vie50.r.cloudfront.net

widgets.financialcontent.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2606:4700::6812:12d1 (United States)

ASN13335 (CLOUDFLARENET, US)

mma.prnewswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
rt.prnewswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

8 2a02:26f0:f700:495::1e80 (Vienna, Austria)

ASN20940 (AKAMAI-ASN1, NL)

assets.adobedtm.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.48.61.43 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-52-48-61-43.eu-west-1.compute.amazonaws.com

dpm.demdex.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:214f:3000:18:1fcd:351:7bc1 (United States)

ASN16509 (AMAZON-02, US)

static.chartbeat.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2606:4700::6810:9440 (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.cookielaw.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.231.82.137 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-231-82-137.compute-1.amazonaws.com

ping.chartbeat.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.254.165.240 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-254-165-240.eu-west-1.compute.amazonaws.com

prnewswireassociationllc.demdex.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.171.1.252 (Dublin, Ireland) 1 redirects

ASN16509 (AMAZON-02, US)
PTR: ec2-54-171-1-252.eu-west-1.compute.amazonaws.com

cm.everesttech.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 15.236.117.205 (Paris, France)

ASN16509 (AMAZON-02, US)
PTR: ec2-15-236-117-205.eu-west-3.compute.amazonaws.com

prnewswire.122.2o7.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6812:1a55 (United States)

ASN13335 (CLOUDFLARENET, US)

geolocation.onetrust.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
56	prnewswire.com www.prnewswire.com — Cisco Umbrella Rank: 30353 mma.prnewswire.com — Cisco Umbrella Rank: 36528 rt.prnewswire.com — Cisco Umbrella Rank: 65139	460 KB
8	adobedtm.com assets.adobedtm.com — Cisco Umbrella Rank: 478	86 KB
6	cookielaw.org cdn.cookielaw.org — Cisco Umbrella Rank: 381	118 KB
3	demdex.net dpm.demdex.net — Cisco Umbrella Rank: 201 prnewswireassociationllc.demdex.net — Cisco Umbrella Rank: 70157	5 KB
1	onetrust.com geolocation.onetrust.com — Cisco Umbrella Rank: 619	303 B
1	2o7.net prnewswire.122.2o7.net — Cisco Umbrella Rank: 67175	392 B
1	everesttech.net 1 redirects cm.everesttech.net — Cisco Umbrella Rank: 974	517 B
1	chartbeat.net ping.chartbeat.net — Cisco Umbrella Rank: 1202	201 B
1	chartbeat.com static.chartbeat.com — Cisco Umbrella Rank: 1447	15 KB
1	financialcontent.com widgets.financialcontent.com — Cisco Umbrella Rank: 60103	157 KB
1	c212.net 1 redirects c212.net — Cisco Umbrella Rank: 9753	398 B
78	11

	Domain	Requested by
53	www.prnewswire.com	www.prnewswire.com
8	assets.adobedtm.com	www.prnewswire.com
6	cdn.cookielaw.org	assets.adobedtm.com www.prnewswire.com cdn.cookielaw.org
2	dpm.demdex.net	www.prnewswire.com
2	mma.prnewswire.com	www.prnewswire.com
1	geolocation.onetrust.com	www.prnewswire.com
1	prnewswire.122.2o7.net	www.prnewswire.com
1	cm.everesttech.net	1 redirects
1	prnewswireassociationllc.demdex.net	www.prnewswire.com
1	ping.chartbeat.net	www.prnewswire.com
1	static.chartbeat.com	www.prnewswire.com
1	rt.prnewswire.com	www.prnewswire.com
1	widgets.financialcontent.com	www.prnewswire.com
1	c212.net	1 redirects
78	14

This site contains links to these domains. Also see Links.

Domain
portal.prnewswire.com
www.cision.com
prnmedia.prnewswire.com
gdpr.cision.com
twitter.com
www.facebook.com
www.linkedin.com
c212.net
www.cytosorbents.com
www.smallbusinesspr.com
prnewswire.mediaroom.com
www.prnasia.com
prnewswire.com.br
www.newswire.ca
prnewswire.com.mx
www.prnewswire.co.uk
profnet.prnewswire.com
cookiepedia.co.uk
onetrust.com

Subject Issuer	Validity	Valid
sni.cloudflaressl.com Cloudflare Inc ECC CA-3	`2022-05-28` - `2023-05-28`	a year	crt.sh
financialcontent.com Amazon	`2022-04-06` - `2023-05-05`	a year	crt.sh
assets.adobedtm.com DigiCert TLS RSA SHA256 2020 CA1	`2022-07-19` - `2023-08-19`	a year	crt.sh
*.demdex.com DigiCert TLS RSA SHA256 2020 CA1	`2022-09-26` - `2023-10-27`	a year	crt.sh
*.chartbeat.com Thawte RSA CA 2018	`2022-05-06` - `2023-06-03`	a year	crt.sh
cookielaw.org Cloudflare Inc ECC CA-3	`2022-05-01` - `2023-05-01`	a year	crt.sh
*.chartbeat.net Thawte RSA CA 2018	`2022-12-19` - `2023-12-30`	a year	crt.sh
*.112.2o7.net DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2022-04-08` - `2023-04-20`	a year	crt.sh
onetrust.com Cloudflare Inc ECC CA-3	`2022-12-13` - `2023-12-13`	a year	crt.sh

This page contains 2 frames:

Primary Page: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Frame ID: D69D6D2ADAAC5695812F56DA4CA2D8B2
Requests: 78 HTTP requests in this frame

Frame: https://prnewswireassociationllc.demdex.net/dest5.html?d_nsid=0
Frame ID: 0CB68F35942DA83B7FD7A3786ADA3219
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic SurgeryBack ButtonSearch IconFilter Icon

Page URL History Show full URLs

https://c212.net/c/link/?t=0&l=en&o=3758271-1&h=1125481483&u=https%3A%2F%2Fwww.prnewswire.com... HTTP 302
https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor... Page URL

Detected technologies

Adobe Experience Manager (CMS) Expand

Overall confidence: 100%
Detected patterns

/etc\.clientlibs/

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

RequireJS (JavaScript Frameworks) Expand

Overall confidence: 100%
Detected patterns

require.*\.js

Chartbeat (Analytics) Expand

Overall confidence: 100%
Detected patterns

chartbeat\.js

Clipboard.js (Miscellaneous) Expand

Overall confidence: 100%
Detected patterns

clipboard(?:-([\d.]+))?(?:\.min)?\.js

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Lightbox (JavaScript Libraries) Expand

OneTrust (Cookie compliance) Expand

Overall confidence: 100%
Detected patterns

cdn\.cookielaw\.org
otSDKStub\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

jQuery UI (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery-ui.*\.js

Page Statistics

78
Requests

99 %
HTTPS

46 %
IPv6

11
Domains

14
Subdomains

12
IPs

4
Countries

842 kB
Transfer

2713 kB
Size

8
Cookies

44 Outgoing links

These are links going to different origins than the main page.

URL: https://portal.prnewswire.com/
Title: Send a Release

Search URL Search Domain Scan URL

URL: https://www.cision.com/us/blog/
Title: Blog

Search URL Search Domain Scan URL

URL: https://prnmedia.prnewswire.com/
Title: Journalists

Search URL Search Domain Scan URL

URL: https://gdpr.cision.com/
Title: GDPR

Search URL Search Domain Scan URL

URL: https://twitter.com/PRNewswire

Search URL Search Domain Scan URL

URL: https://www.facebook.com/pages/PR-Newswire/26247320522

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/pr-newswire/

Search URL Search Domain Scan URL

URL: https://portal.prnewswire.com/Login.aspx
Title: Log In

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=206236748&u=http%3A%2F%2Fwww.cytosorbents.com%2F&a=CytoSorbents+Corporation
Title: CytoSorbents Corporation

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=461383361&u=http%3A%2F%2Fwww.cytosorb.com%2F&a=CytoSorb%C2%AE
Title: CytoSorb®

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=2136978274&u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcytosorb-is-approved-and-available-for-the-removal-of-ticagrelor-a-leading-anti-platelet-drug-during-cardiopulmonary-bypass-in-the-eu-300995215.html&a=E.U.+approval+earlier+this+year+to+remove+the+P2Y12+anti-platelet+inhibitor%2C+ticagrelor
Title: E.U. approval earlier this year to remove the P2Y12 anti-platelet inhibitor, ticagrelor

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=3769327163&u=https%3A%2F%2Fwww.pharmaceutical-technology.com%2Ffeatures%2Ftop-selling-prescription-drugs%2F&a=Rivaroxaban+was+the+10th+top+selling+prescription+drug+by+global+revenue+in+2018
Title: Rivaroxaban was the 10th top selling prescription drug by global revenue in 2018

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=3633584851&u=https%3A%2F%2Fwww.xarelto-us.com%2F&a=more+than+40+million+people+worldwide+have+been+prescribed+the+drug
Title: more than 40 million people worldwide have been prescribed the drug

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=48246371&u=https%3A%2F%2Fjournals.sagepub.com%2Fdoi%2Fabs%2F10.1177%2F1060028020902280%3Furl_ver%3DZ39.88-2003%26amp%3Brfr_dat%3Dcr_pub%253Dpubmed%26amp%3Brfr_id%3Dori%253Arid%253Acrossref.org%26journalCode%3Daopd&a=cost+more+than+%2420%2C000+per+dose
Title: cost more than $20,000 per dose

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=2995609846&u=https%3A%2F%2Fwww.xarelto-us.com%2F&a=Rivaroxaban
Title: Rivaroxaban

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=1476214356&u=https%3A%2F%2Fwww.xarelto-us.com%2F&a=Xarelto%C2%AE
Title: Xarelto®

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=3847816506&u=https%3A%2F%2Fwww.bayer.com%2Fen%2Fintegrated-annual-reports.aspx&a=%244.5+billion+in+2019+sales+outside+the+U.S.
Title: $4.5 billion in 2019 sales outside the U.S.

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=1698952583&u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fjohnson--johnson-reports-2019-fourth-quarter-and-full-year-results-300991143.html&a=2019+U.S.+sales+of+%242.3+billion
Title: 2019 U.S. sales of $2.3 billion

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=967882958&u=https%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fben%2Fcpd%2F2018%2F00000024%2F00000038%2Fart00008&a=an+estimated+8-10%25+of+patients+on+anticoagulant+therapy+will+require+emergent+surgery+at+some+point+in+their+lifetime
Title: an estimated 8-10% of patients on anticoagulant therapy will require emergent surgery at some point in their lifetime

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=13159648&u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5156547%2F&a=a+48-hour+washout+period+is+recommended
Title: a 48-hour washout period is recommended

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=2305803968&u=https%3A%2F%2Fwww.annalsthoracicsurgery.org%2Farticle%2FS0003-4975(19)30102-X%2Fpdf&a=in+a+retrospective+case+series+of+patients+(n%3D12)+who+required+emergency+cardiac+surgery+on+rivaroxaban
Title: in a retrospective case series of patients (n=12) who required emergency cardiac surgery on rivaroxaban

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=522880367&u=http%3A%2F%2Fwww.nasdaq.com%2Fsymbol%2Fctso%2Freal-time&a=CTSO
Title: CTSO

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=2302620228&u=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F136867%2Fdownload&a=FDA+Emergency+Use+Authorization
Title: FDA Emergency Use Authorization

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=3928298582&u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fdevelopment-update-us-fda-grants-breakthrough-designation-to-cytosorb-for-removal-of-ticagrelor-during-cardiopulmonary-bypass-in-emergent-and-urgent-cardiothoracic-surgery-301043326.html&a=CytoSorb+has+also+been+granted+FDA+Breakthrough+Designation
Title: CytoSorb has also been granted FDA Breakthrough Designation

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=1757114562&u=http%3A%2F%2Fwww.cytosorbents.com%2F&a=www.cytosorbents.com
Title: www.cytosorbents.com

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=4098198613&u=http%3A%2F%2Fwww.cytosorb.com%2F&a=www.cytosorb.com
Title: www.cytosorb.com

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=445461813&u=https%3A%2F%2Fwww.facebook.com%2Fcytosorbents&a=Facebook
Title: Facebook

Search URL Search Domain Scan URL

URL: https://c212.net/c/link/?t=0&l=en&o=2801338-1&h=4286273464&u=https%3A%2F%2Ftwitter.com%2FCytoSorbents&a=Twitter
Title: Twitter

Search URL Search Domain Scan URL

URL: http://www.cytosorbents.com/
Title: http://www.cytosorbents.com

Search URL Search Domain Scan URL

URL: https://www.facebook.com/PR-Newswire-26247320522/

Search URL Search Domain Scan URL

URL: https://www.smallbusinesspr.com/request_information
Title: For Small Business

Search URL Search Domain Scan URL

URL: https://prnewswire.mediaroom.com/index.php
Title: About PR Newswire

Search URL Search Domain Scan URL

URL: https://www.cision.com/us/?utm_medium=website&utm_source=prnewswire&utm_content=cishomepage&utm_campaign=prnewswire
Title: About Cision

Search URL Search Domain Scan URL

URL: https://www.cision.com/careers/
Title: Careers

Search URL Search Domain Scan URL

URL: https://www.cision.com/us/covid-19-resources/
Title: COVID-19 Resources

Search URL Search Domain Scan URL

URL: https://www.cision.com/about/accessibility/
Title: Accessibility Statement

Search URL Search Domain Scan URL

URL: https://www.prnasia.com/
Title: Asia

Search URL Search Domain Scan URL

URL: https://prnewswire.com.br/
Title: Brazil

Search URL Search Domain Scan URL

URL: https://www.newswire.ca/
Title: Canada

Search URL Search Domain Scan URL

URL: https://prnewswire.com.mx/
Title: Mexico

Search URL Search Domain Scan URL

URL: https://www.prnewswire.co.uk/
Title: United Kingdom

Search URL Search Domain Scan URL

URL: https://profnet.prnewswire.com/ProfNetHome/What-is-Profnet.aspx
Title: ProfNet

Search URL Search Domain Scan URL

URL: https://cookiepedia.co.uk/giving-consent-to-cookies
Title: More information

Search URL Search Domain Scan URL

URL: https://onetrust.com/poweredbyonetrust

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://c212.net/c/link/?t=0&l=en&o=3758271-1&h=1125481483&u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html&a=rivaroxaban HTTP 302
https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 67

https://cm.everesttech.net/cm/dd?d_uuid=66657118656838558752807331256965401269 HTTP 302
https://dpm.demdex.net/ibs:dpid=411&dpuuid=Y8c7pgAAAHtpSwNn

78 HTTP transactions
1 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html Show response
www.prnewswire.com/news-releases/
Redirect Chain

https://c212.net/c/link/?t=0&l=en&o=3758271-1&h=1125481483&u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel...
https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html

170 KB
26 KB

70ms
25ms

Document
text/html

2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

eb7327c427fe0e7a9438ddf7fb4533019cf175ddac101b3d631f8d9ca3db95d8

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
age: 38542
cache-control: public, max-age=172800
cf-cache-status: HIT
cf-ray: 78b32c68dcd8bbb0-FRA
content-encoding: gzip
content-type: text/html; charset=UTF-8
date: Wed, 18 Jan 2023 00:21:57 GMT
expires: Fri, 20 Jan 2023 00:21:57 GMT
last-modified: Mon, 16 Jan 2023 18:41:02 GMT
server: cloudflare
strict-transport-security: max-age=31536000; includeSubDomains; preload
vary: Accept-Encoding
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block

Redirect headers

content-length: 0
date: Wed, 18 Jan 2023 00:21:57 GMT
location: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
server: Jetty(9.4.31.v20200723)
server-timing: intid;desc=b0b0c7a9bb6f8c21
via: 1.1 f8fe53d5464b299529d281799da8de30.cloudfront.net (CloudFront)
x-amz-cf-id: Y7E_aUjuZirGmVJbGBfKiuEI33AHTzVmZpHdb__PoiHuY70wcDkaQA==
x-amz-cf-pop: FRA2-C2
x-cache: Miss from cloudfront

GET
H2 200 stockquote.js Show response
widgets.financialcontent.com/cision/ 156 KB
157 KB 111ms
38ms Script
application/javascript 99.86.240.36
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://widgets.financialcontent.com/cision/stockquote.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 99.86.240.36 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-99-86-240-36.vie50.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 2bda5f95c6a89e0389b3c7f7346d93ef97cab16653bbbf4d659b32b1f46c9e33

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
via: 1.1 2a3d03f915cb6d29f35b8f9edd3b1956.cloudfront.net (CloudFront)
last-modified: Tue, 13 Sep 2022 19:27:15 GMT
server: AmazonS3
x-amz-cf-pop: VIE50-C1
age: 19
etag: "d59cdbe38f9e9a3a200f2976b4f93eef"
x-cache: Hit from cloudfront
content-type: application/javascript; charset=UTF-8
cache-control: max-age=60
accept-ranges: bytes
content-length: 160115
x-amz-cf-id: FwNPocp_J2M3hB5IhzE8NBLsScFQnx_mx_zEFvf60revtJt1qNtwHw==

GET
H2 200 clientlib-library.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/ 90 KB
32 KB 27ms
27ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlib-library.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5430fd47d87d8f981a93966d9760372c5ba5306e76f8e966ebf9d80f03d6430d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337922
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 03:43:14 GMT
server: cloudflare
etag: W/"16767-5ef5cf4108b6b"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c692d11bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 component-clientlibs.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/ 3 KB
1 KB 22ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/component-clientlibs.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4d05b9f152f060af3dfd420b0d0efa393be700d6c21c00548541b22c978e5682

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337922
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 02:30:09 GMT
server: cloudflare
etag: W/"a63-5ef5beeb95886"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c692d12bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 newspage-clientlibs.min.css
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/ 407 KB
64 KB 31ms
31ms Stylesheet
text/css 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

10869a75c245526b124cd5e936d8f64e5688bda89dae42bf4b841a5bb5f6d380

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337922
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 04:05:10 GMT
server: cloudflare
etag: W/"65c21-5ef5d4285ff15"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: text/css
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c692d13bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 prn_cision_logo_desktop.png
www.prnewswire.com/content/dam/prnewswire/homepage/ 7 KB
7 KB 28ms
26ms Image
image/png 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.prnewswire.com/content/dam/prnewswire/homepage/prn_cision_logo_desktop.png

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

efc1b56943f822a78573e3abcc164fa499e5d21ae96ea8b43ee76cb02d27ffa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 209524
content-length: 7468
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Sep 2022 17:55:40 GMT
server: cloudflare
etag: "1d2c-5e842411189f1"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: image/png
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=28800
accept-ranges: bytes
cf-ray: 78b32c698d51bbb0-FRA
expires: Wed, 18 Jan 2023 08:21:57 GMT

GET
H2 200 clientlibs.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/components/global/menu/ 406 B
379 B 22ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/components/global/menu/clientlibs.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c065328a66f3112ee2e29612bbafa89d8a0c0aeb176dbceef08d9e7ac256fedf

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 416080
server-timing: intid;desc=843a628196062c9f
content-length: 195
x-xss-protection: 1; mode=block
last-modified: Fri, 02 Sep 2022 02:58:45 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript;charset=utf-8
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
accept-ranges: bytes
cf-ray: 78b32c697d37bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 prn_cision_logo_mobile.png
www.prnewswire.com/content/dam/prnewswire/homepage/ 4 KB
4 KB 27ms
26ms Image
image/png 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.prnewswire.com/content/dam/prnewswire/homepage/prn_cision_logo_mobile.png

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d55fbf4e2affca026d12185094dc44d109ae759e91f4a8da75b5069499f85c0b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 208927
content-length: 4398
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Sep 2022 16:57:37 GMT
server: cloudflare
etag: "112e-5e841716f2881"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: image/png
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=28800
accept-ranges: bytes
cf-ray: 78b32c698d53bbb0-FRA
expires: Wed, 18 Jan 2023 08:21:57 GMT

GET
H2 200 share_clientlibs.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/ 2 KB
971 B 24ms
21ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/share_clientlibs.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5d6e3638105a16751e5d00c28b82f351f678eb7150f71ae0927b8f76717ee077

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337920
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 03:24:49 GMT
server: cloudflare
etag: W/"969-5ef5cb23c12c8"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c698d48bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 CytoSorbents_Working_To_Save_Lives_Logo.jpg
mma.prnewswire.com/media/1096384/ 4 KB
4 KB 51ms
20ms Image
image/jpeg 2606:4700::6812:12d1
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://mma.prnewswire.com/media/1096384/CytoSorbents_Working_To_Save_Lives_Logo.jpg?w=200
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 2606:4700::6812:12d1 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare / ASP.NET
Resource Hash: a889101373a333b361a85a5309e727427b3c18d3d1f83df153b5c678e9a41df4

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
cf-cache-status: HIT
age: 38063
x-powered-by: ASP.NET
server-timing: intid;desc=7ec745256a598378
content-length: 3958
cf-bgj: h2pri
last-modified: Tue, 17 Jan 2023 13:47:34 GMT
server: cloudflare
vary: *, Accept-Encoding
access-control-allow-methods: GET, POST, OPTIONS
content-type: image/jpeg
access-control-allow-origin: *
cache-control: public, max-age=1
accept-ranges: bytes
cf-ray: 78b32c69b9e192b4-FRA
access-control-allow-headers: Content-Type
expires: Tue, 17 Jan 2023 13:47:35 GMT

GET
H2 200 rt.gif
rt.prnewswire.com/ 0
310 B 457ms
409ms Image
image/gif 2606:4700::6812:12d1
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://rt.prnewswire.com/rt.gif?NewsItemId=NY04826&Transmission_Id=202005120708PR_NEWS_USPR_____NY04826&DateId=20200512
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 2606:4700::6812:12d1 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
cf-cache-status: DYNAMIC
server: cloudflare
cf-ray: 78b32c69d8222c79-FRA
content-length: 0
vary: User-Agent
content-type: image/gif

GET
H2 200 CytoSorbents_Working_To_Save_Lives_Logo.jpg
mma.prnewswire.com/media/1096384/ 3 KB
3 KB 50ms
19ms Image
image/jpeg 2606:4700::6812:12d1
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://mma.prnewswire.com/media/1096384/CytoSorbents_Working_To_Save_Lives_Logo.jpg?p=thumbnail
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Protocol: H2
Security: TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server: 2606:4700::6812:12d1 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare / ASP.NET
Resource Hash: 0166b34c642f44ede8d8ffdeaccac360b63834264e956c84b1faa07035850bb8

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
cf-cache-status: HIT
age: 38063
x-powered-by: ASP.NET
server-timing: intid;desc=b2f5f4cbf61babaf
content-length: 2611
cf-bgj: h2pri
last-modified: Tue, 17 Jan 2023 13:47:34 GMT
server: cloudflare
vary: *, Accept-Encoding
access-control-allow-methods: GET, POST, OPTIONS
content-type: image/jpeg
access-control-allow-origin: *
cache-control: public, max-age=1
accept-ranges: bytes
cf-ray: 78b32c69b9e292b4-FRA
access-control-allow-headers: Content-Type
expires: Tue, 17 Jan 2023 13:47:35 GMT

GET
H2 200 email-decode.min.js Show response
www.prnewswire.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/ 1 KB
774 B 18ms
16ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	DENY

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 10 Jan 2023 19:32:51 GMT
server: cloudflare
etag: W/"63bdbd63-4d7"
vary: Accept-Encoding
x-frame-options: DENY
content-type: application/javascript
cache-control: max-age=172800, public
cf-ray: 78b32c698d4abbb0-FRA
expires: Fri, 20 Jan 2023 00:21:57 GMT

GET
H2 200 jquery.min.js Show response
www.prnewswire.com/etc.clientlibs/clientlibs/granite/ 98 KB
35 KB 26ms
23ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1d5dcc1f5ef70e9ab2b6190c1bc183d8c7b7bb7e37f99a2a426174c5c4f2b7c5

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 217109
x-xss-protection: 1; mode=block
last-modified: Sun, 19 Apr 2020 09:23:18 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript;charset=utf-8
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c698d4bbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 utils.min.js Show response
www.prnewswire.com/etc.clientlibs/clientlibs/granite/ 8 KB
3 KB 27ms
25ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/utils.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

06bff916cefa0e2d5595ee421e0e8652f349e85c0a14a6e6921f4368200a9629

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 227276
content-length: 3359
x-xss-protection: 1; mode=block
last-modified: Sun, 19 Apr 2020 09:23:18 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript;charset=utf-8
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
accept-ranges: bytes
cf-ray: 78b32c698d4cbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 granite.min.js Show response
www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/ 4 KB
2 KB 25ms
23ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4125f7fb5ef940e03901ec9b35eb9a9345427aaf6348976e7b9521b6322919f8

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 227276
content-length: 1626
x-xss-protection: 1; mode=block
last-modified: Sat, 18 Apr 2020 21:39:04 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript;charset=utf-8
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
accept-ranges: bytes
cf-ray: 78b32c698d4ebbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 require.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 15 KB
6 KB 30ms
28ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/require.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

82b01b3224333278089e33819a299fc2db29b7262032c8734e24cc15e6c58b81

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337920
cf-polished: origSize=15923
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 16:13:56 GMT
server: cloudflare
etag: W/"3e33-5f227853da2fa"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c698d4fbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 ticker_model.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/ 905 B
727 B 29ms
27ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/ticker_model.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

fdbbb507db34f1dd8594960e6116a1c9d5d3cacde6bfa6b16f9482305fbd01eb

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337921
cf-polished: origSize=1004
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:30:12 GMT
server: cloudflare
etag: W/"3ec-5ef5beee44dc1"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c698d50bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 montserrat-v10-latin-regular.woff2
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/montserrat/ 15 KB
15 KB 27ms
26ms Font
application/octet-stream 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/montserrat/montserrat-v10-latin-regular.woff2

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e7907501c0d4588fa7529b23d8c6d5b9cdc3e35c656c1d96d704a406704bac01

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
Origin: https://www.prnewswire.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 226855
content-length: 15148
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 03:24:33 GMT
server: cloudflare
etag: "3b2c-5ef5cb13fd98a"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
accept-ranges: bytes
cf-ray: 78b32c699d5cbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 BlackTie-Regular-webfont.woff2
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/regular/ 13 KB
13 KB 22ms
22ms Font
application/octet-stream 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/regular/BlackTie-Regular-webfont.woff2?v=1.0.0

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

15c730c302225ad29a32a1852a683e1c02f45e4e8a018bef6c7901a51458e62d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
Origin: https://www.prnewswire.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
age: 60049
content-length: 12928
x-xss-protection: 1; mode=block
last-modified: Sun, 19 Apr 2020 12:57:14 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/octet-stream
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=86400
accept-ranges: bytes
cf-ray: 78b32c69ad6cbbb0-FRA
expires: Thu, 19 Jan 2023 00:21:57 GMT

GET
H2 200 BlackTie-Bold-webfont.woff2
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/bold/ 12 KB
12 KB 26ms
26ms Font
application/octet-stream 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/bold/BlackTie-Bold-webfont.woff2?v=1.0.0

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

15bf31befca38b1b05bb31331a90d28a7a7855ee63332203f747f9bb338dcdf5

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
Origin: https://www.prnewswire.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
age: 58431
content-length: 12276
x-xss-protection: 1; mode=block
last-modified: Sun, 19 Apr 2020 12:57:14 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/octet-stream
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=86400
accept-ranges: bytes
cf-ray: 78b32c69cd83bbb0-FRA
expires: Thu, 19 Jan 2023 00:21:57 GMT

GET
H2 200 FontAwesomeBrands-Regular-webfont.woff2
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/brands/ 20 KB
20 KB 24ms
24ms Font
application/octet-stream 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/brands/FontAwesomeBrands-Regular-webfont.woff2?v=1.0.0

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4a7acdea55252ab19b8c6e010eb38e2c11e87fee77e390798ce207b13b883d2d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
Origin: https://www.prnewswire.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
age: 60081
content-length: 19972
x-xss-protection: 1; mode=block
last-modified: Sun, 19 Apr 2020 12:57:14 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/octet-stream
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=86400
accept-ranges: bytes
cf-ray: 78b32c69cd85bbb0-FRA
expires: Thu, 19 Jan 2023 00:21:57 GMT

GET
H2 200 montserrat-v10-latin-600.woff2
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/montserrat/ 15 KB
15 KB 22ms
22ms Font
application/octet-stream 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/montserrat/montserrat-v10-latin-600.woff2

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e6822c4bf502293c833706d8c854d45c22aa3630b479cec820ab717926acfc0c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
Origin: https://www.prnewswire.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: HIT
age: 226852
content-length: 15412
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 03:24:33 GMT
server: cloudflare
etag: "3c34-5ef5cb1425653"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
accept-ranges: bytes
cf-ray: 78b32c69cd88bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 BlackTie-Solid-webfont.woff2
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/solid/ 10 KB
10 KB 24ms
24ms Font
application/octet-stream 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/fonts/black-tie/solid/BlackTie-Solid-webfont.woff2?v=1.0.0

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8e59eebce9d687cd91cd3e9b16b97d1a8b75605f833400cc55f38f7c64669eda

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
Origin: https://www.prnewswire.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
age: 57068
content-length: 10164
x-xss-protection: 1; mode=block
last-modified: Sun, 19 Apr 2020 12:57:14 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/octet-stream
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=86400
accept-ranges: bytes
cf-ray: 78b32c69cd89bbb0-FRA
expires: Thu, 19 Jan 2023 00:21:57 GMT

GET
H2 200 token.json Show response
www.prnewswire.com/libs/granite/csrf/ 2 B
122 B 21ms
21ms XHR
application/json 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/libs/granite/csrf/token.json

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
age: 147357
content-length: 2
x-xss-protection: 1; mode=block
last-modified: Mon, 16 Jan 2023 07:26:00 GMT
server: cloudflare
x-frame-options: SAMEORIGIN, SAMEORIGIN
vary: Accept-Encoding
content-type: application/json;charset=iso-8859-1
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=28800
accept-ranges: bytes
cf-ray: 78b32c6a2dd8bbb0-FRA
expires: Wed, 18 Jan 2023 08:21:57 GMT

GET
H2 200 common.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/ 13 KB
2 KB 23ms
23ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/common.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1da6bb93dd43643084b1beb50d2a2f0c52deae32c446f35f640b43cd90168e1f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337920
cf-polished: origSize=15920
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:24:33 GMT
server: cloudflare
etag: W/"3e30-5ef5cb1437f3b"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6a5dfabbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 jquery.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlib-library/resources/js/ 141 KB
40 KB 30ms
29ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlib-library/resources/js/jquery.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

86b1e8f819ee2d9099a783e50b49dff24282545fc40773861f9126b921532e4c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337920
cf-polished: origSize=287629
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 16:29:40 GMT
server: cloudflare
etag: W/"4638d-5f227bd809575"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6a8e1dbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 page.template-b.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/ 264 B
276 B 22ms
21ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/page.template-b.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a9a929c937f4e78e4c5c693f2f3b664223cf6b30c0b77a039dc3fc11a25d281f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337919
cf-polished: origSize=404
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 14:38:08 GMT
server: cloudflare
etag: W/"194-5f2262e9c8881"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6a8e1fbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lightbox.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 4 KB
2 KB 24ms
24ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/lightbox.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

da273328be1361cb68b02b5418eb0b1a3594713a10a8b95ecdfb4c054ebc940d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337919
cf-polished: origSize=6453
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:55:02 GMT
server: cloudflare
etag: W/"1935-5ef5c47ae1b7f"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe37bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lightbox-analytics.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 3 KB
867 B 25ms
24ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/lightbox-analytics.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

929ea7e41e865f866b64df661eb4fc8506ae374f706cc13fb495b653e2aad013

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
cf-polished: origSize=5451
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 18:02:17 GMT
server: cloudflare
etag: W/"154b-5f22908b4069f"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe38bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 masonry.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 566 B
559 B 22ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/masonry.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6d50335b64de9f714ba0b77a1cb90541e8e4a7cc93198da61a79819d80f6adbe

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337536
cf-polished: origSize=1008
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 17:09:27 GMT
server: cloudflare
etag: W/"3f0-5f2284bcd7d74"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe39bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 to-clipboard.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 100 B
228 B 21ms
20ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/to-clipboard.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

633e002cee9ae0ba313b725231d81019792cc991a409d6c81b8f4ff733cf8772

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
cf-polished: origSize=116
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 10:42:45 GMT
server: cloudflare
etag: W/"74-5f222e4d63a78"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe3abbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 smooth-scroll.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 378 B
359 B 26ms
26ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/smooth-scroll.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

58d097f9de6e54cb45e089367f06b9ceff167379c01a937c3cb66f8c8cfdb2c3

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337537
cf-polished: origSize=553
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Thu, 08 Dec 2022 18:34:29 GMT
server: cloudflare
etag: W/"229-5ef55499f5e3e"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe3bbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 just-read.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 288 B
304 B 24ms
24ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/just-read.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e8db02f7b9e330dd84d40c0d06bd972043785b556ca2eb74d7bc1c115ea002fe

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337536
cf-polished: origSize=348
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:17:28 GMT
server: cloudflare
etag: W/"15c-5ef5bc159adab"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe3dbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 mobile-share.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 280 B
351 B 21ms
21ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/mobile-share.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1fb4622665623b055901a94005186f18566307843e65053ec401789ced02b184

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337537
cf-polished: origSize=310
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 17:09:27 GMT
server: cloudflare
etag: W/"136-5f2284bcdac54"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe3fbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 twitter.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/ 3 KB
1 KB 23ms
23ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/twitter.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

101107192014a062d77db70ad6598f317c00430b8086fa674f7a0c6931dbcf6b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337537
cf-polished: origSize=3464
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 14:40:11 GMT
server: cloudflare
etag: W/"d88-5f22635fa6023"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6abe40bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 jquery-ui.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 249 KB
66 KB 26ms
26ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/jquery-ui.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

793cb14b4ae48e92c4a35eae5d34b4b95092e3cd7995ce342b6895a560ef7526

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
x-xss-protection: 1; mode=block
last-modified: Fri, 13 Jan 2023 16:09:37 GMT
server: cloudflare
etag: W/"3e46a-5f22775d2b5ca"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6ace4cbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 imagesloaded.pkgd.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 12 KB
3 KB 26ms
26ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/imagesloaded.pkgd.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a61bb67587744b4ac04eaf84901f4a1b583829e503427ea102acb219d5e5c999

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337536
cf-polished: origSize=28233
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Thu, 08 Dec 2022 18:14:24 GMT
server: cloudflare
etag: W/"6e49-5ef5501c452d2"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6aee69bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lightgallery.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 43 KB
9 KB 26ms
25ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/lightgallery.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c297eb4fa76c7dd130fd78fa820bb4d3a6569523f6d93a4e238fc061c21ad729

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 02:35:07 GMT
server: cloudflare
etag: W/"adcf-5ef5c007b8b79"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6aee6abbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 bootstrap.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 39 KB
11 KB 24ms
24ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/bootstrap.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6db0bb8f0b7a8e36d6d89acf7bdda9565fc0129414592bd8009f23098f6755f6

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
cf-polished: origSize=39680
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:24:34 GMT
server: cloudflare
etag: W/"9b00-5ef5cb14b0536"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b3e9bbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lg-share.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 4 KB
1 KB 24ms
23ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/lg-share.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

0ed3c1bc3251ca0228cba9fbe371f1b33ea4ac525be8dfbe01f84a0b093877db

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
x-xss-protection: 1; mode=block
last-modified: Fri, 13 Jan 2023 07:24:41 GMT
server: cloudflare
etag: W/"f68-5f220207ea2a5"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b3ea7bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lg-thumbnail.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 7 KB
2 KB 27ms
27ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/lg-thumbnail.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2bba8db002fcedc76570379f9000b60218528db66bbbc52d526c90750682a9cf

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 03:43:19 GMT
server: cloudflare
etag: W/"1d2a-5ef5cf465681c"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b4ea8bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lg-zoom.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 7 KB
2 KB 23ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/lg-zoom.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f248f708a0dc14c698e3e4e1b9dc1cef176d582a48ea72b6ba2b825d720d1882

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 02:35:07 GMT
server: cloudflare
etag: W/"1d97-5ef5c007e13fa"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b4ea9bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lg-video.min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 6 KB
2 KB 22ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/lg-video.min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c073c0672830242a97c77ce1de2372e0bacaefdc0f6698b64b90b01148683bce

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
x-xss-protection: 1; mode=block
last-modified: Fri, 09 Dec 2022 02:55:03 GMT
server: cloudflare
etag: W/"169b-5ef5c47bb1038"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b4eaabbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 jquery.bridget.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 2 KB
935 B 24ms
24ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/jquery.bridget.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

499b99e267cba47ea5111172f7b19e378af42de2dcdff2b5cea66cd7c6a97a71

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337919
cf-polished: origSize=3683
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 13 Jan 2023 16:38:15 GMT
server: cloudflare
etag: W/"e63-5f227dc2bf02b"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b5eb6bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 stickynav.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 1 KB
667 B 27ms
26ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/stickynav.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e4d455cf988af7439d5d40934e7afb98cc9a6b5489bc9064a04ad9d888ba08b9

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
cf-polished: origSize=2070
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:30:13 GMT
server: cloudflare
etag: W/"816-5ef5beef1ee65"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ec3bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 mobilenav.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 4 KB
2 KB 26ms
24ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/mobilenav.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2af6693afb9eb54a2111baf163ee7a08ebd5954d6233372d5e456ac43baefbc7

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
cf-polished: origSize=9391
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:49:47 GMT
server: cloudflare
etag: W/"24af-5ef5c34e9a569"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ec4bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 search.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 3 KB
1 KB 24ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/search.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5738d335b21d44cb2c7336bd0ef9cecf9e18785713d0117199153c07099f7c48

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337916
cf-polished: origSize=4284
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:24:34 GMT
server: cloudflare
etag: W/"10bc-5ef5cb14cfd2c"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ec5bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 subnav.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 7 KB
3 KB 26ms
25ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/subnav.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

acbe075506cce6cb437aefaf6f223e7f8ff7ad1a30b7fdb015fa3987ebd9b4a3

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337916
cf-polished: origSize=10359
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:24:34 GMT
server: cloudflare
etag: W/"2877-5ef5cb14cfd2c"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ec6bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 lazyload-min.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 2 KB
1 KB 23ms
21ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/lazyload-min.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5b3baa10ac55f4eece0c7e666eaddd51872b8ce9273671626bcccec8f86ead78

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
x-xss-protection: 1; mode=block
last-modified: Fri, 13 Jan 2023 17:50:08 GMT
server: cloudflare
etag: W/"8a2-5f228dd41a99b"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ec7bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 search-script.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 12 KB
3 KB 28ms
27ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/search-script.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c7c341314e765dcd68e12b57e8e5ab776c8227b84f216d3fcb5499a256e77956

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
cf-polished: origSize=18781
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:30:13 GMT
server: cloudflare
etag: W/"495d-5ef5beef257e0"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ec8bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 accessibility.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 512 B
293 B 24ms
21ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/accessibility.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

91a3509ee4fbc62651990b760a6b671070c8130f24ff22cc2e0c3efdf23a382e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337916
cf-polished: origSize=661
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:30:13 GMT
server: cloudflare
etag: W/"295-5ef5beef253f8"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ecabbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 mycnw-login.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 3 KB
1 KB 27ms
25ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/mycnw-login.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f129909a96d751d4b245a14a9c4fe16f7eef54a4ca1980ff05a3d6122538aff1

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 139258
cf-polished: origSize=4128
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Thu, 08 Dec 2022 18:12:36 GMT
server: cloudflare
etag: W/"1020-5ef54fb4f4dec"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6ecbbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 launch-ENb957f6e7383d4549b191e1190ed5476e.min.js Show response
assets.adobedtm.com/ 391 KB
67 KB 108ms
19ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/launch-ENb957f6e7383d4549b191e1190ed5476e.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 7eb5f84abc79d25fe0a1d0f0eb4b05a95e94ece906867ca902dc205036adcbec

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
last-modified: Thu, 15 Dec 2022 12:35:13 GMT
server: AkamaiNetStorage
etag: "a464feaace326a3f9d574ee01a094b10:1671107713.043807"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 68654
expires: Wed, 18 Jan 2023 01:21:57 GMT

GET
H2 200 footer.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 303 B
228 B 28ms
26ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/footer.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ce7c4d0822ca4d04fc5ef4f16be9b8bf8c5e1a7a06605f2612ae6d9139492bd9

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337917
cf-polished: origSize=339
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 02:30:13 GMT
server: cloudflare
etag: W/"153-5ef5beef2b1ba"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6b6eccbbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 masonry.pkgd.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 42 KB
11 KB 26ms
26ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/masonry.pkgd.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

aa0821fd01c7cb3d169ccf4e3aa034692182e54bc84bb5495d89f10fe6d8b54c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337918
cf-polished: origSize=87114
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:24:50 GMT
server: cloudflare
etag: W/"1544a-5ef5cb24a9dd4"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6baef3bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 jquery.mmenu.min.all.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/ 59 KB
15 KB 26ms
25ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/lib/jquery.mmenu.min.all.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

326159007a313a01727520cecb63ec921f11cd6387409fb3a415e64545abe6db

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337916
cf-polished: origSize=134523
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:24:34 GMT
server: cloudflare
etag: W/"20d7b-5ef5cb14e6496"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6bcf13bbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H2 200 icon-toggle.js Show response
www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/ 530 B
415 B 22ms
22ms Script
application/javascript 2606:4700::6812:1855
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.prnewswire.com/etc.clientlibs/prncom/clientlibs/clientlibs-common/resources/js/prncom/icon-toggle.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.2, ECDHE_ECDSA, AES_128_GCM

Server

2606:4700::6812:1855 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

0632fac6645023188cbc0868d957390ebfe5ccf93a250a4181ee40dba6cecbe8

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
cf-cache-status: HIT
age: 337916
cf-polished: origSize=905
x-xss-protection: 1; mode=block
cf-bgj: minify
last-modified: Fri, 09 Dec 2022 03:43:20 GMT
server: cloudflare
etag: W/"389-5ef5cf469c94f"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: https://app.zoominfo.com; *.prnewswire.com; *.multivu.com; *.vocusdr.com; *.prweb.com
cache-control: public, max-age=432000
cf-ray: 78b32c6bdf1ebbb0-FRA
expires: Mon, 23 Jan 2023 00:21:57 GMT

GET
H/1.1 200
OK id Show response
dpm.demdex.net/ 383 B
1 KB 148ms
31ms XHR
application/json 52.48.61.43
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=A807776A5245B2E10A490D44%40AdobeOrg&d_nsid=0&ts=1674001317844

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.48.61.43 Dublin, Ireland, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-52-48-61-43.eu-west-1.compute.amazonaws.com

Software

Resource Hash

b4395ca90e1110279fc3a9ea9e2ab3c9e170e3115720a97e4ecd13ba7314a4bf

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36
Content-Type: application/x-www-form-urlencoded

Response headers

DCS: dcs-prod-irl1-1-v045-0333db6ef.edge-irl1.demdex.com 2 ms
Pragma: no-cache
Strict-Transport-Security: max-age=31536000; includeSubDomains
content-encoding: gzip
X-TID: uiVxqeeoQLY=
Vary: Origin
P3P: policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin: https://www.prnewswire.com
Content-Type: application/json;charset=utf-8
Cache-Control: no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 321
Expires: Thu, 01 Jan 1970 00:00:00 UTC

GET
H2 200 AppMeasurement.min.js Show response
assets.adobedtm.com/extensions/EPbf7b42aa08bc4f10879b1484195e80d1/ 34 KB
12 KB 19ms
19ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/extensions/EPbf7b42aa08bc4f10879b1484195e80d1/AppMeasurement.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: d6d01246a30e9d483531c27721f73f266fa4af35effdb21683ac02a620ab8aaf

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
last-modified: Thu, 22 Sep 2022 16:16:49 GMT
server: AkamaiNetStorage
etag: "dfdd9e1f988805f0c2fbb10cd6b8f034:1663863409.614694"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: no-cache
accept-ranges: bytes
timing-allow-origin: *
content-length: 12384
expires: Wed, 18 Jan 2023 01:21:57 GMT

GET
H2 200 AppMeasurement_Module_ActivityMap.min.js Show response
assets.adobedtm.com/extensions/EPbf7b42aa08bc4f10879b1484195e80d1/ 3 KB
2 KB 20ms
20ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/extensions/EPbf7b42aa08bc4f10879b1484195e80d1/AppMeasurement_Module_ActivityMap.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 78c1c1baf0d964522f8afab09cfc754685c1648826a7f9967fd52b774b4ec5aa

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
last-modified: Thu, 22 Sep 2022 16:16:49 GMT
server: AkamaiNetStorage
etag: "b89fcb8870ac40eecb6d3cc844d35389:1663863409.92483"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: no-cache
accept-ranges: bytes
timing-allow-origin: *
content-length: 1598
expires: Wed, 18 Jan 2023 01:21:57 GMT

GET
H2 200 chartbeat.js Show response
static.chartbeat.com/js/ 37 KB
15 KB 57ms
8ms Script
application/x-javascript 2600:9000:214f:3000:18:1fcd:351:7bc1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://static.chartbeat.com/js/chartbeat.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:214f:3000:18:1fcd:351:7bc1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: nginx /
Resource Hash: 7b307f2ce73aec07bfa1ab1d6462f491de0497c8819b1d6fed66eda9638a3530

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Tue, 17 Jan 2023 02:57:12 GMT
content-encoding: gzip
via: 1.1 110641d379117242a91443ac729d6dee.cloudfront.net (CloudFront)
last-modified: Thu, 08 Dec 2022 17:25:10 GMT
server: nginx
x-amz-cf-pop: FRA53-C1
age: 77085
etag: W/"63921df6-9377"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/x-javascript
cache-control: max-age=86400
cross-origin-resource-policy: cross-origin
x-amz-cf-id: iSHk2mHh5nwZmJsU0LRoxVFPtzLPvewRBKp0NTjhRvmdVfVqNKSN-g==
expires: Wed, 18 Jan 2023 02:57:12 GMT

GET
H2 200 RCd6422194b5574cefbcd6fb6bf0df1662-source.min.js Show response
assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/ 725 B
682 B 18ms
18ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/RCd6422194b5574cefbcd6fb6bf0df1662-source.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: f26e412315cc6bc5ed66b7783af39f568779dcc14dfd3582b593be9da6f1dddd

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
last-modified: Thu, 15 Dec 2022 12:35:13 GMT
server: AkamaiNetStorage
etag: "527d01f9b69fb979f5489abaf3ac11de:1671107713.85286"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 414
expires: Wed, 18 Jan 2023 01:21:57 GMT

GET
H2 200 otSDKStub.js Show response
cdn.cookielaw.org/scripttemplates/ 24 KB
8 KB 68ms
26ms Script
application/javascript 2606:4700::6810:9440
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/otSDKStub.js

Requested by

Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/launch-ENb957f6e7383d4549b191e1190ed5476e.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:9440 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3d277a90920d78efa3d6e473d67240beb26100591c7b02a34bd444aa78ee5d5c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: WdCEPqU1pnnoNr/cT9hHyQ==
age: 39466
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 8053
x-ms-lease-status: unlocked
last-modified: Mon, 16 Jan 2023 03:33:49 GMT
server: cloudflare
etag: 0x8DAF7727B43570F
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: 94786c06-701e-00f3-6e08-2a0b8f000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 78b32c6d3faa2be5-FRA

GET
H2 200 RCba5514e037384efbba82cbb0f4962191-source.min.js Show response
assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/ 6 KB
2 KB 18ms
18ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/RCba5514e037384efbba82cbb0f4962191-source.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 9a23a9cd4115121944da13aabd32f39174f888fef37d22dfea06bc5f8dabac0b

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:57 GMT
content-encoding: gzip
last-modified: Thu, 15 Dec 2022 12:35:13 GMT
server: AkamaiNetStorage
etag: "527d01f9b69fb979f5489abaf3ac11de:1671107713.85286"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 1922
expires: Wed, 18 Jan 2023 01:21:57 GMT

GET
H2 200 ping
ping.chartbeat.net/ 43 B
201 B 340ms
108ms Image
image/gif 3.231.82.137
AMAZON-AES

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ping.chartbeat.net/ping?h=prnewswire.com&p=%2Fnews-releases%2Fcytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html&u=JvlUpwpkPXWTYEr&d=prnewswire.com&g=66222&g0=news-releases%2CNew%20Jersey%2CPDT%2CHEA%2CMEQ%2CMTC%2COTC%2CMultimedia&g1=CytoSorbents%20Corporation&nc=1&c=0&x=0&m=0&y=4893&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&PA=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html&b=1072&t=DErfDWDrCf6OCdzIoJB593RUQ6C4Y&V=139&i=CytoSorb%C2%AE%20is%20E.U.%20Approved%20to%20Remove%20Rivaroxaban%2C%20a%20Leading%20Factor%20Xa%20Inhibitor%20and%20Novel%20Oral%20Antic&tz=0&sn=1&sv=kRasHBip91UC2O9xaCw06m4BNMsjP&sd=1&im=067b2fff&_
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.231.82.137 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-231-82-137.compute-1.amazonaws.com
Software: /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

content-type: image/gif
pragma: no-cache
date: Wed, 18 Jan 2023 00:21:58 GMT
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
content-length: 43
expires: 0

GET
H2 200 074a1b2c-06ca-4946-a4c7-6e9c5c87fb77.json Show response
cdn.cookielaw.org/consent/074a1b2c-06ca-4946-a4c7-6e9c5c87fb77/ 7 KB
3 KB 34ms
19ms XHR
application/x-javascript 2606:4700::6810:9440
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/consent/074a1b2c-06ca-4946-a4c7-6e9c5c87fb77/074a1b2c-06ca-4946-a4c7-6e9c5c87fb77.json

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:9440 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

23127014f2b932fbfceeabf85fa2798459bf67391dd1d349236bdeddd6451ac9

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: 8/SxLcMKThm45ZSMh68G2w==
age: 58432
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 1974
x-ms-lease-status: unlocked
last-modified: Mon, 06 Jun 2022 06:25:14 GMT
server: cloudflare
etag: 0x8DA4785510DDCB8
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: 1a68e43f-301e-013c-6481-792a68000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 78b32c6d9e83993f-FRA
expires: Thu, 19 Jan 2023 00:21:58 GMT

GET
H/1.1 200
OK dest5.html Show response
prnewswireassociationllc.demdex.net/ Frame 0CB6 7 KB
3 KB 156ms
31ms Document
text/html 34.254.165.240
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://prnewswireassociationllc.demdex.net/dest5.html?d_nsid=0

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

34.254.165.240 Dublin, Ireland, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-34-254-165-240.eu-west-1.compute.amazonaws.com

Software

Resource Hash

7bea17a80a61ed0f54248b4ffc4c718f7c8ff2619742577a73591d62ce074da8

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

Accept-Ranges: bytes
Cache-Control: no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection: keep-alive
Content-Length: 2791
Content-Type: text/html;charset=UTF-8
DCS: dcs-prod-irl1-1-v045-0a637d725.edge-irl1.demdex.com 0 ms
Expires: Thu, 01 Jan 1970 00:00:00 UTC
P3P: policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma: no-cache
Strict-Transport-Security: max-age=31536000; includeSubDomains
X-TID: +ti8CCwnQfs=
content-encoding: gzip
date: Wed, 18 Jan 2023 00:21:58 GMT
last-modified: Fri, 28 Oct 2022 11:02:56 GMT
vary: accept-encoding

GET
H/1.1

200
OK

ibs:dpid=411&dpuuid=Y8c7pgAAAHtpSwNn
dpm.demdex.net/
Redirect Chain

https://cm.everesttech.net/cm/dd?d_uuid=66657118656838558752807331256965401269
https://dpm.demdex.net/ibs:dpid=411&dpuuid=Y8c7pgAAAHtpSwNn

42 B
942 B

44ms
43ms

Image
image/gif

52.48.61.43
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://dpm.demdex.net/ibs:dpid=411&dpuuid=Y8c7pgAAAHtpSwNn

Requested by

Protocol

HTTP/1.1

Server

52.48.61.43 Dublin, Ireland, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-52-48-61-43.eu-west-1.compute.amazonaws.com

Software

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

DCS: dcs-prod-irl1-2-v045-0ebeee8d5.edge-irl1.demdex.com 2 ms
Pragma: no-cache
Strict-Transport-Security: max-age=31536000; includeSubDomains
content-encoding: gzip
X-Content-Type-Options: nosniff
X-TID: tIfRdc7HQNA=
P3P: policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Content-Type: image/gif
Cache-Control: no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection: keep-alive
Content-Length: 59
Expires: Thu, 01 Jan 1970 00:00:00 UTC

Redirect headers

Location: https://dpm.demdex.net/ibs:dpid=411&dpuuid=Y8c7pgAAAHtpSwNn
Date: Wed, 18 Jan 2023 00:21:58 GMT
Cache-Control: no-cache
Server: AMO-cookiemap/1.1
Connection: keep-alive
Content-Length: 0
P3P: CP="NOI NID DEVa PSAa PSDa OUR IND PUR COM NAV INT DEM"

POST
H2 200 s01961593879360 Show response
prnewswire.122.2o7.net/b/ss/prnewswirecom2/1/JS-2.23.0-LCXS/ 43 B
392 B 59ms
17ms XHR
image/gif 15.236.117.205
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://prnewswire.122.2o7.net/b/ss/prnewswirecom2/1/JS-2.23.0-LCXS/s01961593879360

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

15.236.117.205 Paris, France, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-15-236-117-205.eu-west-3.compute.amazonaws.com

Software

jag /

Resource Hash

55c9d2f019f9d7ddfd69b2ad0351c5617338a222362aebb02b3b98a4dbc18486

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

pragma: no-cache
date: Wed, 18 Jan 2023 00:21:58 GMT
x-content-type-options: nosniff
last-modified: Thu, 19 Jan 2023 00:21:58 GMT
server: jag
etag: 3594890459145928704-4619364720687442605
vary: *
p3p: CP="This is not a P3P policy"
access-control-allow-origin: https://www.prnewswire.com
content-type: image/gif;charset=utf-8
cache-control: no-cache, no-store, max-age=0, no-transform, private
access-control-allow-credentials: true
content-length: 43
x-xss-protection: 1; mode=block
expires: Tue, 17 Jan 2023 00:21:58 GMT

GET
H2 200 location Show response
geolocation.onetrust.com/cookieconsentpub/v1/geo/ 66 B
303 B 91ms
35ms XHR
application/json 2606:4700::6812:1a55
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:1a55 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f90d159c7a961f8d49cf0197de9f4a31f91310b5cd03edc042f82beae766c88b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept: application/json
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:58 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
server: cloudflare
vary: Accept-Encoding
access-control-allow-methods: GET, OPTIONS
content-type: application/json
access-control-allow-origin: *
cf-ray: 78b32c6e1cd29150-FRA
access-control-allow-headers: Content-Type

GET
H2 200 otBannerSdk.js Show response
cdn.cookielaw.org/scripttemplates/6.10.0/ 356 KB
78 KB 30ms
29ms Script
application/javascript 2606:4700::6810:9440
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js

Requested by

Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:9440 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

7a23e0e46e16f067271bc79c92a917c13769848457d16cdf109e4dc04c687e8f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: Bh9exWOPGIwRshWljrtlEw==
age: 39459
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 79698
x-ms-lease-status: unlocked
last-modified: Thu, 03 Dec 2020 02:43:00 GMT
server: cloudflare
etag: 0x8D89735260901BC
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: d3ece154-601e-00ce-76d2-a7bea9000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 78b32c6e68a92be5-FRA

GET
H2 200 en.json Show response
cdn.cookielaw.org/consent/074a1b2c-06ca-4946-a4c7-6e9c5c87fb77/db203d6d-62a8-4d5e-a525-7f0857685cb8/ 62 KB
15 KB 23ms
22ms Fetch
application/x-javascript 2606:4700::6810:9440
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/consent/074a1b2c-06ca-4946-a4c7-6e9c5c87fb77/db203d6d-62a8-4d5e-a525-7f0857685cb8/en.json

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:9440 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3e206a143d50120c881b69fe7bf2b6ee02bd15cd69c0dbc96d89030bd7aa250a

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: i1F4Qv5nVthgUH7ST4m90g==
age: 2799
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 14881
x-ms-lease-status: unlocked
last-modified: Mon, 06 Jun 2022 06:25:31 GMT
server: cloudflare
etag: 0x8DA47855B9ED30D
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: 2e133f14-d01e-013d-5286-792b95000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 78b32c6ecf88993f-FRA
expires: Thu, 19 Jan 2023 00:21:58 GMT

GET
H2 200 otCenterRounded.json Show response
cdn.cookielaw.org/scripttemplates/6.10.0/assets/ 9 KB
3 KB 25ms
25ms Fetch
application/json 2606:4700::6810:9440
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/6.10.0/assets/otCenterRounded.json

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:9440 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

452ee2471448cc6b716090a014cf7fc9cc515998bda9dcc334aa073a72a591e7

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: SH1nUCPouc1JVrHnvxpQbg==
age: 58171
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 2857
x-ms-lease-status: unlocked
last-modified: Thu, 03 Dec 2020 02:42:51 GMT
server: cloudflare
etag: 0x8D89735210A49EB
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: a973a4a1-701e-00f3-296f-cb0b8f000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 78b32c6effa7993f-FRA

GET
H2 200 otPcCenter.json Show response
cdn.cookielaw.org/scripttemplates/6.10.0/assets/v2/ 46 KB
11 KB 16ms
16ms Fetch
application/json 2606:4700::6810:9440
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/6.10.0/assets/v2/otPcCenter.json

Requested by

Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:9440 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3b27f686e9c39188ff63e191cc3efb6500a6c6d06f2d1d2ec27ceb623a2ecacc

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: ydfMbMpHX/N/aS5YhkXXwQ==
age: 58171
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 11336
x-ms-lease-status: unlocked
last-modified: Thu, 03 Dec 2020 02:42:53 GMT
server: cloudflare
etag: 0x8D89735220FDD9F
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: 70de6025-b01e-00aa-0de6-290e09000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 78b32c6effa8993f-FRA

GET
DATA 200
OK truncated
/ 817 B
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: db311174b0e3c340727b63c055cfb5b317808e909503e1bda11cc58af444f12b

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

Content-Type: image/svg+xml

GET
H2 200 RC3e8a8698479648919ac4ebad82b4446b-source.min.js Show response
assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/ 547 B
603 B 18ms
18ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/RC3e8a8698479648919ac4ebad82b4446b-source.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 6f1ea320bde7aaa8dd43c1331f28fb03b893882e5c1a9f281c1a75e3e92dd5b0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
last-modified: Thu, 15 Dec 2022 12:35:13 GMT
server: AkamaiNetStorage
etag: "527d01f9b69fb979f5489abaf3ac11de:1671107713.85286"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 335
expires: Wed, 18 Jan 2023 01:21:58 GMT

GET
H2 200 RC0fac000949e94e008e8243a58a0cbf83-source.min.js Show response
assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/ 854 B
755 B 18ms
18ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/RC0fac000949e94e008e8243a58a0cbf83-source.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 807ee6addc01c726852ff98c0eac0f12d40d302af7ae3cb8c8459d27a90d3ebc

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
last-modified: Thu, 15 Dec 2022 12:35:13 GMT
server: AkamaiNetStorage
etag: "527d01f9b69fb979f5489abaf3ac11de:1671107713.85286"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 487
expires: Wed, 18 Jan 2023 01:21:58 GMT

GET
H2 200 RC8ef25184ebf84f3d9dcff6180e5521fa-source.min.js Show response
assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/ 633 B
662 B 18ms
18ms Script
application/x-javascript 2a02:26f0:f700:495::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/f8e1ad0aec1d/d06ab2f346fe/251b6d3c83c4/RC8ef25184ebf84f3d9dcff6180e5521fa-source.min.js
Requested by: Host: www.prnewswire.com
URL: https://www.prnewswire.com/etc.clientlibs/clientlibs/granite/jquery/granite.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:f700:495::1e80 Vienna, Austria, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: d7bcce27c788317d472584d5e0a16443975e07e143d744b8888e7e55a3bcd767

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.prnewswire.com/news-releases/cytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/109.0.5414.74 Safari/537.36

Response headers

date: Wed, 18 Jan 2023 00:21:58 GMT
content-encoding: gzip
last-modified: Thu, 15 Dec 2022 12:35:13 GMT
server: AkamaiNetStorage
etag: "527d01f9b69fb979f5489abaf3ac11de:1671107713.85286"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: https://www.prnewswire.com
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 394
expires: Wed, 18 Jan 2023 01:21:58 GMT

Verdicts & Comments Add Verdict or Comment

75 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

8 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
.prnewswire.com/	1970-01-20 09:00:03	Name: __cf_bm Value: K5._dOXvdPCPVNDHHlmi0NIJu.z82hD6xEwYpoFIoVc-1674001317-0-AeKbvXVB5YUjEgxmXxUVnIHBg8PnK6CB51P90FcOsC0//EQJkgag/EnQ2aVWPJiWPZK/2ekyH/9/te9fAi0AzTI=
.demdex.net/	1970-01-20 13:19:13	Name: demdex Value: 66657118656838558752807331256965401269
.prnewswire.com/	1969-12-31 23:59:59	Name: AMCVS_A807776A5245B2E10A490D44%40AdobeOrg Value: 1
.prnewswire.com/	1969-12-31 23:59:59	Name: s_cc Value: true
.everesttech.net/	1970-01-20 17:45:37	Name: everest_g_v2 Value: g_surferid~Y8c7pgAAAHtpSwNn
.dpm.demdex.net/	1970-01-20 13:19:13	Name: dpm Value: 66657118656838558752807331256965401269
.prnewswire.com/	1970-01-20 18:36:01	Name: AMCV_A807776A5245B2E10A490D44%40AdobeOrg Value: 1585540135%7CMCIDTS%7C19376%7CMCMID%7C62717959313782050673277807354162086205%7CMCAAMLH-1674606118%7C6%7CMCAAMB-1674606118%7C6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y%7CMCOPTOUT-1674008518s%7CNONE%7CMCSYNCSOP%7C411-19383%7CvVersion%7C4.4.0
.prnewswire.com/	1970-01-20 13:19:13	Name: OptanonConsent Value: isIABGlobal=false&datestamp=Wed+Jan+18+2023+00%3A21%3A58+GMT%2B0000+(GMT)&version=6.10.0&hosts=&consentId=beddf47c-e031-4405-9665-ea793087465c&interactionCount=0&landingPath=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcytosorb-is-eu-approved-to-remove-rivaroxaban-a-leading-factor-xa-inhibitor-and-novel-oral-anticoagulant-during-on-pump-cardiothoracic-surgery-301057276.html&groups=C0001%3A1%2CC0002%3A0%2CC0003%3A0%2CC0004%3A0

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

assets.adobedtm.com
c212.net
cdn.cookielaw.org
cm.everesttech.net
dpm.demdex.net
geolocation.onetrust.com
mma.prnewswire.com
ping.chartbeat.net
prnewswire.122.2o7.net
prnewswireassociationllc.demdex.net
rt.prnewswire.com
static.chartbeat.com
widgets.financialcontent.com
www.prnewswire.com
13.225.78.23
15.236.117.205
2600:9000:214f:3000:18:1fcd:351:7bc1
2606:4700::6810:9440
2606:4700::6812:12d1
2606:4700::6812:1855
2606:4700::6812:1a55
2a02:26f0:f700:495::1e80
3.231.82.137
34.254.165.240
52.48.61.43
54.171.1.252
99.86.240.36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www.prnewswire.com Open in urlscan Pro 2606:4700::6812:1855 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

78 Requests

99 %HTTPS

46 %IPv6

11 Domains

14 Subdomains

12 IPs

4 Countries

842 kBTransfer

2713 kBSize

8 Cookies

44 Outgoing links

Page URL History

Redirected requests

78 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 1 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

www.prnewswire.com Open in urlscan Pro
2606:4700::6812:1855 Public Scan

Screenshot
Live screenshot

Full Image

78
Requests

99 %
HTTPS

46 %
IPv6

11
Domains

14
Subdomains

12
IPs

4
Countries

842 kB
Transfer

2713 kB
Size

8
Cookies

78 HTTP transactions
1 data transactions